The replication of vaccinia virus is thought to take place exclusively in the cytoplasm of host cells. However, using DNA-DNA hybridization techniques, it can be shown that a significant fraction of the synthesis of vaccinia DNA takes place in the nucleus as well as the cytoplasm. The [3H ]thymidine pulse-labeled vaccinia DNA synthesized in the nucleus reaches a maximum at about 3 h after infection, corresponding to the time of maximal DNA synthesis in infected cells. At this time host DNA synthesis drops to about 25% of the rate of the uninfected cells. Even with short labeling times (2 min) the nucleus is found to contain 60% of the incorporated [3H]thymidine, much of which is in vaccinia DNA. Prior inhibition of host nuclear DNA synthesis with mitomycin C, followed by removal of the antibiotic, causes a subsequent inhibition of vaccinia DNA synthesis and complete suppression of mature virus. Purified nuclei, isolated from vacciniainfected cells, also synthesize vaccinia DNA in vitro. Over 90% of the DNA synthesized in vitro by isolated nuclei contain vaccinia-specific sequences.
The examination of vaccinia-infected cells by autoradiography (4) and fluorescent antibody staining (20) indicated that vaccinia DNA replicates and virions undergo maturation in large cytoplasmic aggregates (factories). Subsequently, Joklik and Becker (16) demonstrated that the replicating viral DNA, as well as the parental viral DNA, is associated with large cytoplasmic structures which are presumably the same as the vaccinia virosomes identified by autoradiography and electron microscope studies. It is from these factories, starting at 3 to 4 h postinfection, that progressively increasing amounts of viral DNA are released and become combined with the viral core and coat proteins. Dahl and Kates (6, 7) extended these studies by determining the sedimentation and the density characteristics of parental and newly replicated vaccinia DNA. They showed that the isolated cytoplasmic viral DNA-protein complexes synthesize mRNA sequences with an endogenous RNA polymerase. The mRNA synthesized in vitro is either "early" or "early and late" in accordance with the time of virosome isolation, i.e., before or after vaccinia DNA synthesis has commenced. Moreover, Prescott et formation of aggregates which show DNA synthesis. However, Pennington and Follet (29) were unable to detect the formation of mature vaccinia virions in enucleated cells.
There are also experiments which suggest a nuclear involvement in vaccinia biosynthesis; Reich and Franklin (31) demonstrated that mitomycin C-treated L-cells, whose nuclei synthesize no DNA at the time of vaccinia infection, are unable to support vaccinia DNA replication and infectious virus formation. Under the same conditions Mengo virus replicated its RNA and produces infectious progeny. Cells that are blocked in metaphase by vinblastin are also unable to support vaccinia DNA synthesis and virus replication (24) . Under the same conditions, frog virus DNA and polio virus continue to replicate normally in the cytoplasm (14, 23) .
Walen (36) , by autoradiography, found that the DNA of the infecting vaccinia particles is first associated with the cell chromosomes and that, at later times, intranuclear foci of thymidine incorporation appear to move from the nucleus to the cytoplasm and become part of typical cytoplasmic virosomes. The host DNA is degraded during the first hours after vaccinia infection, and part of this degraded DNA eventually appears in cytoplasmic foci associated with the viral factories (26) . Citarella and co-workers (5) The cells, at a concentration of 2 x 107 cells/ml, were allowed to swell at 0 C for 5 to 10 min in 10 mM NaCl, 5 mM EDTA, and 1 mM KPO4 (pH 7.3) (buffer 2) and then broken in a Dounce homogenizer to give more than 95% cell disruption. Centrifugation at 500 x g for 3 min was used to remove the crude nuclei from the cytoplasmic fraction. The crude nuclear pellet was further purified by suspension of 108 nuclei in 5 ml of 0.32 M sucrose plus 1 mM KPO4 (pH 7.3) containing 0.3% Triton N101 (Ruger Chemical Co.) (buffer 3) followed by Dounce homogenization. The nuclei were pelleted by centrifugation at 500 x g for 3 min, and suspended in buffer 3. After Dounce homogenization to break any clumps, the nuclei were layered onto 25 ml of a 1 M sucrose solution made in buffer 3 and centrifuged at 1,000 x g for 7 min.
The examination of the nuclear pellet after this last purification step with the phase-contrast microscope and by electron microscopy of thin sections showed no intact cells or visible contamination from cytoplastic debris, intact virus, or vaccinia-specific aggregates. Dahl and Kates (6, 7) have previously reported that much higher centrifugal forces are required to sediment the cytoplasmic vaccinia aggregates.
DNA extraction from purified virions. Purified virions were suspended at 20 absorbancy units at 260 nm per ml in 50 mM Tris-hydrochloride (pH 7.8) containing 0.15 M NaCl and 10 mM EDTA. After addition of sodium deoxycholate (to 0.5%) and Pronase (to 1 mg/ml), the mixture was incubated 6 h at 37 C. The solution was extracted three times with phenol-chloroform (50:50) at 4 C, and the DNA was precipitated with 2 volumes of ethanol at -20 C. The DNA was redissolved in 10 mM NaCl, 10 mM EDTA, and 5 mM Tris (pH 7.4) and treated with pancreatic RNase (20 ug/ml) for 30 min at 37 C. The solution was extracted several times with phenol-chloroform and then dialyzed against 0.015 M NaCl-0.0015 M sodium citrate.
DNA extraction from purified nuclei or cytoplasm. Purified nuclei were suspended at 107 nuclei/ml in 50 mM Tris-hydrochloride (pH 7.8) containing 0.15 M NaCl and 10 mM EDTA and incubated 6 h at 37 C with 0.5% sodium dodecyl sulfate and Pronase (1 mg/ml). DNA was then isolated from the solution as described for the vaccinia virions. Cytoplasmic fractions were brought to the salt concentrations given above for the nuclear DNA extraction, and the same procedure was then followed.
DNA synthesis in purified nuclei. Nuclei were prepared by the detergent washing procedure of Berkowitz (1) The incubation was performed at 37 C for 20 min, followed by chilling to 0 C and isolation of the nuclei from the assay mixture by centrifugation. DNA was prepared from the nuclei as described above.
DNA-DNA hybridization. Membrane filters containing vaccinia DNA (5 ug/filter), extracted from purified virus, or HeLa DNA (50 Ag/filter), extracted from nuclei of uninfected cells, were made according to Gillespie and Spiegelman (10) using Sartorius nitrocellulose membranes SM11306. The DNA-DNA annealing method was as described by Denhardt (9) . The input 3H-labeled DNA was denatured by incubating in 0.3 N NaOH at 37 C for 15 (4, 6, 7, 16, 20) . A small amount of hybridization to HeLa DNA filters is observed with the cytoplasmic DNA from infected cells. This may indicate that some host DNA has been released from broken nuclei into the cytoplasm or that mitochondrial DNA synthesis is occurring. It was surprising, however, to find that the nuclei of these vaccinia-infected cells seemed to contain appreciable quantities of labeled vaccinia DNA in addition to the labeled host DNA. As stated above, these nuclei were extensively purified by washing and sedimentation in detergent-containing solutions and were free of visible cytoplasmic or viral contamination in the electron or light microscope.
Nonadsorption of cytoplasmic vaccinia DNA by nuclei. Since part of the pulse-labeled Nuclei were also incubated, in the same way, with 3H-labeled DNA extracted from purified vaccinia virus (1 x 106 counts/min total) or 3H-labeled DNA purified from uninfected HeLa cells (2 x 106 counts/min total). The nuclei isolated from these mixtures again contained insignificant amounts of radioactivity. In addition, other pgrification procedures used to obtain nuclei were tested (3, 28, 32) , and the results obtained were the same as those found with our standard procedure both in the total amount of 3H-labeled DNA (cytoplasmic or nuclear) recovered and in the hybridization results.
We have also carried out dilution experiments with vaccinia-infected HeLa cells which were pulse labeled for 20 minutes with [3H ]thymidine beginning at 3 h after infection. These labeled cells were divided into portions and mixed with various amounts of cytoplasm obtained from nonlabeled 3-h infected cells. The nuclei were then purified from [3H ]labeled infected cells, in the presence or absence of exogenous vaccinia-infected cytoplasm, and their DNA was examined by DNA-DNA hybridization. The nuclei obtained from labeled infected cells which had been broken in the absence of exogenous cytoplasm or in the presence of a two-or fourfold excess of unlabeled cytoplasm showed, in each case, the same total amount of 3H-labeled DNA (2.7 i 0.2 x 106 counts/min) and the same percentage of vaccinia specific DNA (50% Fig. 1A ).
The data in Table 2 and Fig. 1A Table 2 . The DNA-DNA hybridization conditions were as described. The data indicate the fraction of all fore, unexpected. To ascertain the nature of the pulse-labeled DNA in these nuclei, the labeled DNA was hybridized against vaccinia or HeLa DNA-containing filters. Table 2 shows that both HeLa and vaccinia DNA are synthesized in the nuclei of infected cells. By 3 h postinfection, approximately 65% of the pulse-labeled nuclear DNA is vaccinia DNA. This is also shown in Fig. 1B , in which the hybridization data shown in Table 2 have been normalized to the hybridization efficiency obtained with HeLa DNA filters and known 3H-labeled HeLa DNA (15.3%, see Table 2 ) or with vaccinia DNA filters and 3H-labeled vaccinia DNA from purified virions (55.6%, see Table 1 ). The hybridization data of Table 2 Table 3 ). The data is expressed as described in the legend to Fig. 1B thesis in control, uninfected cells rises slightly over a period of 5 h (Fig. 2A) . Infected cells show a marked burst of DNA synthesis which reaches a maximum at 4 h postinfection and then drops sharply. Under these conditions, the bulk of the newly synthesized DNA in the vaccinia-infected cell is found in the nucleus. This may be contrasted to the results obtained in a normal infection where the nuclei contain only 30% of the total labeled DNA found in the cell (Table 2, Fig. 1A) . DNA hybridization studies ( Table 2 , Fig. 2B ) again show that a significant proportion (about 40%) of the pulse-labeled nuclear DNA is vaccinia specific at 3 to 4 h after infection. As (Table 4) . A large part of this DNA is vaccinia DNA, and the data resembles that shown in Table 3 for the 10-min pulse. This data would tend to eliminate the rapid transfer of cytoplasmically synthesized vaccinia DNA into the nucleus as an explanation for the data reported herein, but does not completely exclude this possibility. Conversely, it would also indicate that the vaccinia DNA found in the cytoplasm is not derived from the nucleus and that the synthesis of viral DNA occurs in both compartments.
Synthesis of vaccinia DNA in isolated nuclei. Purified, detergent-washed nuclei, isolated from vaccinia-infected cells, also are capable of synthesizing vaccinia DNA in vitro. Such nuclei, incubated with 'H-labeled deoxynucleoside triphosphates under the proper conditions as described above produce newly synthesized DNA which is predominantly vaccinia DNA. Approximately 95% of the 'H-labeled DNA made by the isolated nuclei contains vaccinia DNA sequences which hybridize to a vaccinia DNA filter (Table 5 ). The isolated nuclei from vaccinia-infected cells thus reflect the in vivo findings in which both vaccinia and HeLa DNA synthesis is observed to occur in the nucleus. The isolated nuclei, in fact, show a higher percentage of vaccinia DNA synthesis than found in vivo and may represent a useful system for further studies in this area. Control experiments, in which the same number of nuclei (5 x 107) obtained from uninfected cells, were incubated with 5 gg of exogenous vaccinia DNA under the same conditions showed little de novo vaccinia DNA synthesis (5% of the total).
Vaccinia infection in mitomycin C-treated cells. To further investigate the possible role of the cell nucleus in vaccinia DNA synthesis, we followed viral DNA synthesis in cells in which the host nuclear DNA synthesis is shut off by treatment with mitomycin C (34, 35) . The synthesis of the viral DNA of frog virus 3, which replicates in the cytoplasm, has been reported not to be inhibited by this drug (23) . The effect of mitomycin C on vaccinia virus replication has been investigated by Kit et al. (21) , who found that cells, infected for 1 to 2 h (in the presence of 15 gg of mitomycin per ml), synthesized DNA at about 20% the rate of mitomycin- treated, uninfected cells. Reich and Franklin (31) found that mitomycin inhibited the production of infectious virus and DNA synthesis at 6 to 8 h after infection. We have examined vaccinia DNA and virus formation in cells which have been exposed to mitomycin C followed by -moval of the antibiotic prior to infection with 1irus.
freatment of growing HeLa cells with 10 jig of mitomycin C per ml causes a rapid decrease in DNA synthesis with a minor inhibition of either RNA or protein synthesis. After 5 h of treatment with mitomycin C, DNA synthesis is inhibited by 95%, whereas RNA and protein synthesis are inhibited 10 and 20%, respectively. If, at this point, the cells are removed from the mitomycin, placed in fresh medium, and then infected with vaccinia virus, synthesis of vaccinia DNA, as measured by DNA-DNA hybridization, is again found to occur both in the nucleus and cytoplasm (Table 6 ). However, the rate of vaccinia DNA synthesis in the nucleus or cyto- a HeLa S3 cells, pretreated for 5 h with 10 ug of mitomycin C, were infected with vaccinia virus at 10 PFU/cell for 1 h at 37 C. The unadsorbed virus was removed by washing, and the cells were reincubated at 37 C in F-13 medium. At Fractionation of cells, nuclear DNA extraction, and hybridization conditions were as described. Input DNA for hybridization was 150 ,g per sample, and the percentage of hybridization is corrected for the blank values. plasm in these mitomycin-pretreated cells (Table 6 ) is about 5 to 10% of that found in untreated, infected cells ( (Table 6 ). Nevertheless, it is clear that even under conditions in which the synthesis of both host and viral DNA are markedly inhibited, a significant proportion of the newly synthesized vaccinia DNA is located in the nucleus. Though total viral DNA synthesis in these pretreated cells is inhibited 95%, the kinetics of vaccinia DNA synthesis in the cytoplasm and nucleus parallels the synthesis in the normal infection.
We have also assayed the number of infectious virus produced after 24 h by cells pretreated with mitomycin C for 5 h before infection, and found it to be 0.4% of that produced by untreated control cells. Thus, pretreatment of host cells to stop host nuclear DNA synthesis has a profound effect on subsequent replication of vaccinia DNA and production of mature virus.
DISCUSSION
The results in this study suggest that both the nucleus and cytoplasm are involved in the replication of vaccinia virus and that host DNA synthesis is only partially suppressed during viral development. The latter point is in agreement with the data of Jungwirth and Launer (17) , who found that cell DNA synthesis in vaccinia-infected cells is reduced about 75% 6 h after infection. This residual host cell DNA synthesis was unaffected by the multiplicity of infection over a range from 40 to 400 virus particles per cell. Synthesis of nuclear DNA in vaccinia-infected cells was also observed by Cairns (4) in his autoradiographic studies, which visualized centers of virus synthesis in the cytoplasm. Further autoradiographic studies by Walen (36) have suggested that initial DNA replication in vaccinia virus-infected cells is associated with the chromosome. These studies could not distinguish between host and viral DNA synthesis. The use of DNA-DNA hybridization in this paper permits the unequivocal distinction between these two types of DNA. There have been other reports that a functioning nucleus is necessary for vaccinia replication. Miller and Enders (22) showed that leukocytes could not replicate vaccinia virus unless the leukocytes were stimulated by phytohemagglutinin. The same phenomenon has been observed with herpes simplex virus, which is known to replicate its DNA in the nucleus (25) . This is consistent with the report of Marcus and Robbins (24) that metaphase cells cannot support vaccinia replication.
The extensive occurrence of vaccinia DNA in the nucleus of infected cells does not seem to be an artifact occurring during breakage of the cells. Thus, the mixing and reconstruction experiments using unlabeled nuclei from normal or vaccinia-infected cells and [3H ]thymidinelabeled cytoplasm from infected cells do not show adsorption of vaccinia DNA from the cytoplasm by the nucleus. Furthermore, the percentage of pulse-labeled vaccinia DNA found in the nuclei of vaccinia-infected cells can range from 10 to 100% of that found in the cytoplasm (Tables 2 and 3) , depending upon the time and conditions of pulse labeling. Even the shortest pulse label experiments (2 min). show extensive synthesis of vaccinia DNA in the nucleus. Since it is difficult to imagine the movement of large amounts of vaccinia DNA from the cytoplasm to the nucleus in this short time span, we take this as evidence that vaccinia DNA synthesis occurs both within the nucleus and cytoplasm. Nuclear synthesis of vaccinia DNA in infected cells is reflected in the in vitro studies with isolated nuclei obtained from these cells. Such isolated nuclei show significant de novo synthesis of vaccinia DNA and, in fact, produce more viral than host DNA sequences. That this, in turn, is relevant to in vivo events is indicated by the observation that nuclei isolated from uninfected cells, when mixed with exogenous vaccinia DNA, fail to synthesize significant amounts of new vaccinia DNA. These observations, coupled with the finding that cells pretreated with mitomycin C to stop host nuclear DNA synthesis also show a concomitant decrease in subsequent vaccinia DNA synthesis and almost complete abolition of infectious virus formation, might indicate that the nucleus plays some essential role in the replication of vaccinia DNA or mature virus. The possible dependence of vaccinia virus DNA replication on the host nuclear apparatus can be compared to the results of McAuslan and Smith (23) with FV-3, a cytoplasmic virus in which DNA synthesis is unaffected by mitomycin C. Furthermore, these workers showed that absorbed FV-3 DNA can be separated from crude nuclei by simple centrifugation through sucrose. Some vaccinia DNA synthesis, by contrast, does seem to occur in the nucleus, and blockage of the host DNA synthesis will subsequently stop vaccinia DNA synthesis. The relationship of the vaccinia DNA synthesized in the nucleus to that made in the cytoplasm remains unclear. Our data provides no clear evidence of movement of vaccinia DNA from one cellular compartment to another, although this is an obvious possibility which may be pertinent to the biosynthesis of vaccinia DNA.
The presence of vaccinia DNA in the nucleus may be related to the observation of Kates (18) that vaccinia mRNA contains poly(A) sequences. It has been postulated that the poly(A) sequences at the end of mRNA may be involved in transport of mRNA out of the nucleus. The occurrence of poly(A) sequences in vaccinia mRNA presumed to be synthesized and utilized solely in the cytoplasm seemed inconsistent with this postulate, even though a poly(A) polymerase has been reported in vaccinia virus (2) . However, the synthesis of vaccinia DNA in the nucleus, as reported here, may be accompanied by the synthesis of vaccinia mRNA in the nucleus, which could be expected to contain poly(A) sequences.
It is possible that a specific replicative step occurs in the nucleus and that this step is necessary for subsequent synthesis and maturation of the virus in the cytoplasm. The nature of these nuclear events remains to be elucidated, but these findings may give clue to the mechanism of vaccinia DNA replication and be related to the process by which the virus inhibits the synthesis of host DNA (13, 17, 27) .
